Halah Jabbar Kadhim

RESEARCH, TEACHING, or OTHER INTERESTS

Genetics (clinical), Cancer Research, Virology, Biochemistry, Genetics and Molecular Biology

Scopus Publications

Expression level of non-coding (MiR-155) gene as biomarker for severity of coronaviruses infection among vaccinated and non-vaccinated Iraqi patients
Halah Kadhim, Abdulameer Ghareeb, and Mohammed Alhilal
IOS Press
BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 is influenced by genetic and epigenetic factors, including miR-155, which affects immune cell and virus functions and laboratory biomarkers. OBJECTIVE: To evaluates miR-155’s role as a biomarker for SARS-CoV-2 detection and monitoring, examining its significance in identifying infection in both vaccinated and unvaccinated individuals using ROC curve analysis. METHODS: Blood samples were collected from 70 patients who attended Medical City Hospital in Baghdad from June 2022 to April 2023 and were determined to be associated with SARS-CoV-2 (35 patients were hospitalized at the Intensive Care Units due to the severity of their symptoms while the other 35 were left in the hospital upon treatment.). Additionally, 35 samples were collected as a healthy control group. RESULTS: The expression level of miR-155 in the serum of samples showed a high level (fold change: 9.81 ± 5.50) in the severe patients’ group in comparison with the moderate patients’ group (fold change: 4.17 ± 2.93) and healthy group (fold change: 1.08 ± 0.01). To assess the performance of miR-155 and laboratory biomarkers, a (ROC) curve was utilized to determine the sensitivity and specificity. CONCLUSIONS: The miR-155 gene, overexpressed in SARS-CoV-2 patients, correlates with disease activity and severity, potentially serving as a biomarker for diagnosis and a potential therapeutic target.


Toll-Like Receptor-4 Expression Level upon SARS-Cov2 Infection with and without Bacterial/Fungal Secondary and Co-Infection Among Iraqi Patients
H.J. Kadhim, A.M. Ghareeb, and M.G Alhilal
Bulgarian Society for Microbiology (Union of Scientists in Bulgaria)
Cytokine storms are an excessive immune response triggered by severe viral infections, such as SARS-CoV2. Toll-like receptor 4 (TLR-4) is a key player in these storms. Secondary and co-infections can exacerbate the immune response, leading to amplified cytokine release and potentially severe disease outcomes. This review aims to evaluate the expression of TLR-4 in fungal and bacterial infections that are associated with and secondary to SARS-CoV2. The study collected specimens from 70 patients admitted to a Baghdad hospital’s ICUs and 35 healthy controls, aged 15-80 years, from June 2022 to April 2023. Re¬al-time RT-PCR was used for infection detection, while conventional methods were used to isolate patho¬genic microorganisms and the Vitec 2 system. The findings of this study suggest that TLR-4 may play a crucial role in secondary and co-infections in individuals with severe SARS-CoV2. The study implies that increased TLR-4 expression might contribute to the development of bacterial secondary and co-infections. When TLR-4 detects bacterial components, it triggers immune responses aimed at eliminating the bacte¬ria. However, an overactive TLR-4 response may lead to an excessive release of cytokines, resulting in a cytokine storm. This excessive immune response can cause tissue damage and exacerbate the severity of SARS-CoV2. Furthermore, the TLR-4 expression may not significantly contribute to the immune response against co-fungal infections with SARS-CoV-2, despite its role in antiviral responses and bacterial defense.